Jan 13, 2022 / 03:30PM GMT
Jialiang Liang - JPMorgan Chase & Co, Research Division - Research Analyst
Good morning, everyone. Welcome back to the 4th JPMorgan Healthcare Conference. I'm Jial, and I work with senior analyst, Jessica Fye, in the team. And we have the pleasure of having the management team from Lexicon Pharmaceuticals joining us for today's discussion, including CEO, Lonnel Coats. So big thank you to you guys. And I'm going to hand over the Zoom to you and come back during the Q&A section. Lonnel.
Lonnel Coats - Lexicon Pharmaceuticals, Inc. - CEO & Director
Jial, thank you so very much. We really appreciate the opportunity to present how we're progressing forward here at Lexicon. As always, I'd like to start these presentations off by thanking all the extraordinary men and women here in Lexicon who work tirelessly every day to advance our science into the hands of patients.
With that today, on Slide 2, I will be making forward-looking statements. Some of those statements will contain risk. Our risks are outlined in our SEC filings. So let me jump right
Lexicon Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers